Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Johnson and Johnson
Teva
Daiichi Sankyo
Queensland Health
Chinese Patent Office
Citi
Medtronic
Fish and Richardson
Mallinckrodt

Generated: October 19, 2017

DrugPatentWatch Database Preview

DAPSONE Drug Profile

« Back to Dashboard

Which patents cover Dapsone, and what generic Dapsone alternatives are available?

Dapsone is a drug marketed by Par Pharm Inc, Alvogen, Jacobus, Virtus Pharms, Actavis Llc, and Nostrum Labs Inc. and is included in seven NDAs.

The generic ingredient in DAPSONE is dapsone. There are eight drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the dapsone profile page.

Summary for Tradename: DAPSONE

US Patents:0
Applicants:6
NDAs:7
Suppliers / Packagers: see list9
Bulk Api Vendors: see list84
Clinical Trials: see list78
Patent Applications: see list7,185
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DAPSONE at DailyMed

Pharmacology for Tradename: DAPSONE

Ingredient-typeSulfones
Drug ClassSulfone
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Pharm Inc
DAPSONE
dapsone
TABLET;ORAL206505-001Dec 1, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Virtus Pharms
DAPSONE
dapsone
TABLET;ORAL204074-001May 10, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Alvogen
DAPSONE
dapsone
TABLET;ORAL205429-002Jan 7, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Nostrum Labs Inc
DAPSONE
dapsone
TABLET;ORAL203887-002May 6, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Virtus Pharms
DAPSONE
dapsone
TABLET;ORAL204074-002May 10, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Par Pharm Inc
DAPSONE
dapsone
TABLET;ORAL206505-002Dec 1, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Alvogen
DAPSONE
dapsone
TABLET;ORAL205429-001Jan 7, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Jacobus
DAPSONE
dapsone
TABLET;ORAL086842-001Approved Prior to Jan 1, 1982ABRXNoYes► Subscribe► Subscribe► Subscribe
Jacobus
DAPSONE
dapsone
TABLET;ORAL086841-001Approved Prior to Jan 1, 1982ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Llc
DAPSONE
dapsone
TABLET;ORAL204380-002Mar 23, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Farmers Insurance
US Department of Justice
Express Scripts
Federal Trade Commission
Cipla
Dow
Johnson and Johnson
Covington
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot